#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurotrophic keratopathy Myxoid liposarcoma Hypersensitivity pneumonitis Fibrous dysplasia of bone Vaginal cancer Chronic graft versus host disease in skin Sarcoidosis Oesophageal squamous cell carcinoma stage III Thymic carcinoma Liver transplant rejection Hyperadrenocorticism Marginal zone lymphoma refractory Anal squamous cell carcinoma Pulmonary alveolar haemorrhage Bulbospinal muscular atrophy congenital More trials…

    Learn about Rare Diseases

    Alport’s syndrome – Treatment Chordoma – Treatment Progressive multifocal leukoencephalopathy – Treatment Glycogen storage disease type I – Treatment Amyotrophic lateral sclerosis – Basic Information Fabry’s disease – Treatment Leukoencephalopathy – Basic Information KBG syndrome – Diagnostics Methylmalonic acidaemia – Treatment Chronic granulomatous disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avalglucosidase Alfa Betibeglogene Autotemcel Eo2318 Haemophilus Influenzae Ptc518 Telisotuzumab Vedotin Epcoritamab Ecoo1A Oxybutynin Montelukast Sodium SODIUM TETRACHLOROPALLADATE [18F]Fluoro-Peg-Folate Setanaxib Quinapril Hydrochloride Vibozilimod Tildrakizumab Cibotercept Antiemetics And Antinauseants Remibrutinib Acoramidis Hydrochloride More therapies…

    Learn about Your Condition

    Gastric cancer Cerebral amyloid angiopathy Hepatitis B Marfan's syndrome Gout End stage renal disease Hand dermatitis Aortic stenosis Combined immunodeficiency Renal cancer stage IV Skin papilloma Polycystic ovarian syndrome Diarrhoea Follicular lymphoma stage III Catatonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of aldesleukin in children aged 4 to 6 years with autism spectrum disorder whose mothers had immune system activation during pregnancy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Aldesleukin
    France

  • A study testing hydroxychloroquine to reduce brain inflammation in patients with progressive multiple sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    • Multiple sclerosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    Finland

  • Testing continuous versus intermittent treatment with cetuximab, fluorouracil, folinic acid, and irinotecan in patients with newly diagnosed metastatic colorectal cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cetuximab
    • Fluorouracil
    • Folinic Acid
    Germany

  • A study of mirdametinib for infants and toddlers under 24 months of age with neurofibromatosis type 1 associated plexiform neurofibromas

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Germany Spain

  • A Study of Ivosidenib and Azacitidine for Patients Over 55 with Acute Myeloid Leukemia and IDH1 Mutation in Complete Remission

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Ivosidenib
    France

  • Testing avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Avacopan
    • Methylprednisolone
    • Prednisone
    France
Previous Page
1 … 771 772 773 774 775 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!